Healthcare >> CEO Interviews >> October 12, 2001
DAVID E. ROBINSON has served as President and Chief Executive
Officer of Ligand Pharmaceuticals Inc. since 1991 and as Chairman
of the Board of Ligand since 1996. Prior to joining Ligand, he
was Chief Operating Officer at Erbamont, a pharmaceutical
company. Prior to that, Mr. Robinson was President of Adria
Laboratories, Erbamont's North American subsidiary. He also was
employed in various executive positions for more than 10 years by
Abbott Laboratories, most recently as Regional Director of Abbott
Europe. Mr. Robinson received his BA in Political Science and
History from MacQuaire University and his MBA from the University
of South Wales, Australia. Mr. Robinson is Chairman of the Board
and a Director of BIO (Biotechnology Industry Organization), and
a Director of BIOCOM, a San Diego-based regional biomedical
industry trade organization. Profile
an overview of things as they are now?
Mr. Robinson: Ligand is an emerging specialty pharmaceutical company
with what we
